Thomas B Martins
Overview
Explore the profile of Thomas B Martins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
923
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson H, Martins T, Saadalla A, Nandakumar V
Clin Chem Lab Med
. 2024 Nov;
63(4):790-796.
PMID: 39501963
Objectives: Early rheumatoid arthritis (RA) detection is crucial for improving patient prognosis. Anticyclic citrullinated peptide antibodies (anti-CCP) and rheumatoid factors (RF) support RA diagnosis but are undetectable in ∼20 %...
2.
Goldstein S, Winder M, Carter C, Diamond J, Bowles E, Martins T, et al.
Cytokine
. 2024 Oct;
184:156786.
PMID: 39471778
Background: Chylothorax after pediatric cardiac surgery is associated with increased morbidity and mortality. Poor understanding exists regarding inflammation within the pleural fluid. Our aim was to determine the relationship between...
3.
Martins T, Hill H, Peterson L
Clin Immunol
. 2024 Jun;
265:110295.
PMID: 38914359
Assessing T-cell independent antibody response to polysaccharide vaccines is crucial for diagnosing humoral immune deficiencies. However, immunocompetence criteria based on S. pneumoniae vaccination remain unclear. We evaluated IgG antibody vaccine...
4.
Martins T, Hill H, Peterson L
J Immunol Methods
. 2024 May;
529:113681.
PMID: 38701879
Cerebrospinal fluid (CSF) is a critical body fluid to examine in attempts to discover potential biomarkers for neuroinflammatory and other disorders of the central nervous system (CNS). Serum and/or plasma...
5.
LaFon D, Woo H, Fedarko N, Azar A, Hill H, Tebo A, et al.
Clin Immunol
. 2023 Apr;
250:109324.
PMID: 37030524
While hypogammaglobulinemia is associated with COPD exacerbations, it is unknown whether frequent exacerbators have specific defects in antibody production/function. We hypothesized that reduced quantity/function of serum pneumococcal antibodies correlate with...
6.
Williams E, Martins T, Shah K, Hill H, Coiras M, Spivak A, et al.
J Clin Cell Immunol
. 2023 Feb;
13(6).
PMID: 36742994
Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID approximately three months after initial infection. These symptoms are highly variable, and the mechanisms inducing them are yet...
7.
Williams E, Martins T, Hill H, Coiras M, Shah K, Planelles V, et al.
medRxiv
. 2022 Oct;
PMID: 36238724
Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID approximately three months after initial infection. These symptoms are highly variable, and the mechanisms inducing them are yet...
8.
Liu B, Martins T, Peterson L, Hill H
Cytokine
. 2021 Mar;
142:155478.
PMID: 33667962
Coronavirus disease 2019 (COVID-19) is a rapidly evolving infectious/inflammatory disorder which has turned into a global pandemic. With severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as its etiologic agent, severe...
9.
Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite E, Spivak E, et al.
Blood Adv
. 2020 Oct;
4(19):4864-4868.
PMID: 33031540
No abstract available.
10.
Heikal N, Martins T, White S, Willis R, Branch D, Schmidt R, et al.
Am J Clin Pathol
. 2019 Jul;
152(5):638-646.
PMID: 31305881
Objectives: Anti-β2 glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome (APS); however, their use in evaluation remains unclear. Methods: Diagnostic attributes...